Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-21,855
Closed -$200K 3027
2024
Q4
$200K Buy
+21,855
New +$204K ﹤0.01% 2528
2023
Q4
Sell
-477,384
Closed -$2.49M 2681
2023
Q3
$2.49M Sell
477,384
-104,234
-18% -$741K 0.01% 1321
2023
Q2
$6.72M Buy
581,618
+278,227
+92% +$3.28M 0.01% 954
2023
Q1
$3.79M Buy
+303,391
New +$5.81M 0.01% 1192
2021
Q3
Sell
-4,134
Closed -$269K 2162
2021
Q2
$269K Buy
+4,134
New +$262K ﹤0.01% 1677
2021
Q1
Sell
-6,312
Closed -$282K 1911
2020
Q4
$282K Sell
6,312
-16,281
-72% -$562K ﹤0.01% 1188
2020
Q3
$655K Buy
22,593
+9,582
+74% +$301K ﹤0.01% 1067
2020
Q2
$462K Sell
13,011
-108,185
-89% -$4.56M ﹤0.01% 934
2020
Q1
$6.26M Sell
121,196
-21,557
-15% -$1.04M 0.07% 351
2019
Q4
$9.75M Buy
142,753
+83,902
+143% +$5.26M 0.06% 437
2019
Q3
$2.82M Sell
58,851
-167,757
-74% -$8.75M 0.02% 657
2019
Q2
$15.1M Buy
+226,608
New +$17.3M 0.1% 290
2019
Q1
Sell
-77,577
Closed -$9.63M 1498
2018
Q4
$9.63M Buy
+77,577
New +$12.8M 0.07% 366
2018
Q3
Sell
-2,679
Closed -$499K 1838
2018
Q2
$499K Buy
+2,679
New +$446K ﹤0.01% 1356
2017
Q4
Sell
-2,700
Closed -$257K 2170
2017
Q3
$257K Buy
+2,700
New +$260K ﹤0.01% 1596

Other funds holding INGN

Dmitry Balyasny's INGN Position: Q1 2025 in Review

Dmitry Balyasny sold out of Inogen (INGN) in Q1 2025, closing a stake of 21,855 shares — an estimated $200K sold.

Dmitry Balyasny first reported a position in INGN in Q3 2017 and held it in 15 quarters. The position peaked at $15.1M in Q2 2019. 127 funds tracked by Wall St. Rank hold INGN as of Q1 2025.

  • Dmitry Balyasny reported no remaining Inogen position as of Q1 2025 after selling out during the quarter.
  • Dmitry Balyasny sold 21,855 Inogen shares in Q1 2025, an estimated $200K.
  • Dmitry Balyasny first reported a position in Inogen in Q3 2017 and held it in 15 quarters.
  • Dmitry Balyasny's Inogen position peaked at $15.1M in Q2 2019.
  • 127 funds tracked by Wall St. Rank held Inogen as of Q1 2025.

Based on Balyasny Asset Management's 13F filing for Q1 2025, filed 15 May 2025.